Clarify the Role of Inbrija for Parkinson's Disease
Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.
Think of Inbrija as a fast-acting levodopa...it starts to work in about 10 minutes and lasts about an hour. It joins the only other "on demand" option...Apokyn (apomorphine), a subcutaneous injection.
Inbrija is used as needed to treat "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (rigidity, tremor, etc) return, especially as Parkinson's progresses.